Home/Filings/4/0000875320-24-000074
4//SEC Filing

Kewalramani Reshma 4

Accession 0000875320-24-000074

CIK 0000875320other

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 4:29 PM ET

Size

5.9 KB

Accession

0000875320-24-000074

Insider Transaction Report

Form 4
Period: 2024-02-16
Kewalramani Reshma
DirectorCEO & President
Transactions
  • Tax Payment

    Common Stock

    2024-02-16$424.01/sh9,359$3,968,310152,912 total
  • Tax Payment

    Common Stock

    2024-02-20$420.58/sh7,019$2,952,051145,893 total

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1
  • filerCIK 0001735944

Filing Metadata

Form type
4
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 4:29 PM ET
Size
5.9 KB